Squarepoint Ops LLC Neurocrine Biosciences Inc Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Squarepoint Ops LLC holds 68,369 shares of NBIX stock, worth $10.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
68,369
Holding current value
$10.3 Million
% of portfolio
0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$114.58 - $153.15 $7.83 Million - $10.5 Million
68,369 New
68,369 $7.87 Million
Q1 2024

May 15, 2024
SELL
$130.4 - $143.74 $6.44 Million - $7.1 Million
-49,375 Reduced 61.58%
30,806 $4.25 Million
Q4 2023

Feb 14, 2024
SELL
$106.07 - $132.76 $4.01 Million - $5.02 Million
-37,816 Reduced 32.05%
80,181 $10.6 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $4.28 Million - $5.02 Million
-47,839 Reduced 28.85%
117,997 $11.1 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $12.5 Million - $16.3 Million
132,314 Added 394.71%
165,836 $16.8 Million
Q4 2022

Feb 14, 2023
SELL
$106.72 - $127.06 $2.58 Million - $3.07 Million
-24,138 Reduced 41.86%
33,522 $4 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $4.11 Million - $4.81 Million
44,656 Added 343.4%
57,660 $6.12 Million
Q2 2022

Aug 15, 2022
SELL
$75.79 - $100.07 $6.4 Million - $8.45 Million
-84,440 Reduced 86.65%
13,004 $1.27 Million
Q1 2022

May 16, 2022
BUY
$72.45 - $94.81 $2.56 Million - $3.35 Million
35,300 Added 56.8%
97,444 $9.14 Million
Q4 2021

Feb 14, 2022
BUY
$79.65 - $106.22 $3.56 Million - $4.74 Million
44,657 Added 255.37%
62,144 $5.29 Million
Q3 2021

Nov 15, 2021
SELL
$86.18 - $99.03 $151,073 - $173,599
-1,753 Reduced 9.11%
17,487 $1.68 Million
Q2 2021

Aug 16, 2021
BUY
$89.43 - $102.27 $1.47 Million - $1.68 Million
16,393 Added 575.8%
19,240 $1.87 Million
Q1 2021

May 17, 2021
SELL
$87.57 - $119.4 $104,821 - $142,921
-1,197 Reduced 29.6%
2,847 $277,000
Q4 2020

Feb 16, 2021
SELL
$86.91 - $108.33 $851,283 - $1.06 Million
-9,795 Reduced 70.78%
4,044 $388,000
Q3 2020

Nov 16, 2020
BUY
$96.16 - $135.15 $1.33 Million - $1.87 Million
13,839 New
13,839 $1.33 Million
Q2 2020

Aug 14, 2020
SELL
$85.09 - $130.36 $2.69 Million - $4.13 Million
-31,660 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$75.11 - $113.76 $3.97 Million - $6.01 Million
-52,824 Reduced 62.53%
31,660 $2.74 Million
Q4 2019

Feb 14, 2020
SELL
$86.8 - $118.57 $7.05 Million - $9.63 Million
-81,220 Reduced 49.02%
84,484 $9.08 Million
Q3 2019

Nov 14, 2019
BUY
$83.82 - $101.5 $10.7 Million - $12.9 Million
127,195 Added 330.3%
165,704 $14.9 Million
Q2 2019

Aug 14, 2019
SELL
$72.24 - $91.27 $5.34 Million - $6.75 Million
-73,922 Reduced 65.75%
38,509 $3.25 Million
Q1 2019

May 15, 2019
SELL
$69.31 - $91.53 $2.05 Million - $2.71 Million
-29,583 Reduced 20.83%
112,431 $9.91 Million
Q4 2018

Feb 14, 2019
BUY
$68.32 - $124.36 $9.19 Million - $16.7 Million
134,539 Added 1799.85%
142,014 $10.1 Million
Q3 2018

Nov 14, 2018
BUY
$98.88 - $125.85 $215,855 - $274,730
2,183 Added 41.25%
7,475 $919,000
Q2 2018

Aug 14, 2018
BUY
$75.3 - $105.99 $87,272 - $122,842
1,159 Added 28.04%
5,292 $520,000
Q1 2018

May 15, 2018
SELL
$75.88 - $92.43 $5.77 Million - $7.03 Million
-76,098 Reduced 94.85%
4,133 $343,000
Q4 2017

Feb 14, 2018
BUY
$58.53 - $77.59 $3.53 Million - $4.68 Million
60,328 Added 303.11%
80,231 $6.23 Million
Q3 2017

Nov 14, 2017
BUY
$47.97 - $61.28 $954,746 - $1.22 Million
19,903
19,903 $1.22 Million

Others Institutions Holding NBIX

# of Institutions
642
Shares Held
94.9M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.4B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email